(Q44574319)

4 December 2017

P27 does not predict histopathological response to radiochemotherapy in rectal cancer (English)

1 reference

4 December 2017

0 references

11

Claus Rödel

1 reference

4 December 2017

Klaus Günther

1

1 reference

4 December 2017

Arno Dimmler

2

1 reference

4 December 2017

Franz Rödel

3

1 reference

4 December 2017

Udo Reulbach

4

1 reference

4 December 2017

Susanne Merkel

5

1 reference

4 December 2017

Birgit R Bittorf

6

1 reference

4 December 2017

Klaus E Matzel

7

1 reference

4 December 2017

Thomas Papadopoulos

8

1 reference

4 December 2017

Werner Hohenberger

9

1 reference

4 December 2017

Rolf Sauer

10

1 reference

4 December 2017

1 August 2003

1 reference

Journal of Surgical Research

4 December 2017

1 reference

4 December 2017

113

1 reference

4 December 2017

179-188

1 reference

4 December 2017

2

1 reference

Neoadjuvant and adjuvant radio- and radio-chemotherapy of rectal carcinomas

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Pathological features of rectal cancer after preoperative radiochemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by low anterior resection with coloanal anastomosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by local excision

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Low rectal cancer: impact of radiation and chemotherapy on surgical treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: relationship to apoptotic activity, p53 and bcl-2 expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Tumor proliferation in rectal cancer following preoperative irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Molecular prognostic factors in rectal cancer treated by radiation and surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Carcinoma of the rectum. Possible cellular predictors of metastatic potential and response to radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Absence of the cell cycle inhibitor p27Kip1 protein predicts poor outcome in patients with stage I-III colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

p27(kip1) expression in rectal cancer correlates with disease-free survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Prognostic significance of p27(Kip1) expression in colorectal cancer: a clinico-pathological characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Down-regulation of p27 is a significant predictor of poor overall survival and may facilitate metastasis in colorectal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Cyclin E-CDK2 is a regulator of p27Kip1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

A new group of conserved coactivators that increase the specificity of AP-1 transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

p27(Kip1) loss does not predict survival in patients with advanced gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

p27kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long‐term follow‐up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

The role of p27 in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900049-0

10.1016/S0022-4804(03)00049-0

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference